Biohaven annual stock-based compensation
2020
2021
2022
2023
2024
2025
Biohaven Stock-Based Compensation Growth & History (BHVN)
Biohaven's stock-based compensation was $112.4M for fiscal 2025.
View full Biohaven company overviewBiohaven annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $112.4M | $40.4M | +56.14% |
| 2024 | 2024-12-31 | $72.0M | $43.2M | +149.98% |
| 2023 | 2023-12-31 | $28.8M | −$164.8M | −85.13% |
| 2022 | 2022-12-31 | $193.6M | $127.9M | +194.88% |
| 2021 | 2021-12-31 | $65.6M | $36.1M | +122.51% |
| 2020 | 2020-12-31 | $29.5M | — | — |
Biohaven quarterly stock-based compensation
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $19.2M | −$1.6M | −7.92% |
| Q1 2026 | 2026-03-31 | $28.3M | −$24.8M | −46.69% |
| Q4 2025 | 2025-12-31 | $17.0M | $4.3M | +33.54% |
| Q3 2025 | 2025-09-30 | $21.5M | $9.4M | +77.10% |
| Q2 2025 | 2025-06-30 | $20.8M | $8.6M | +70.14% |
| Q1 2025 | 2025-03-31 | $53.1M | $18.2M | +52.14% |
| Q4 2024 | 2024-12-31 | $12.7M | −$3.2M | −20.02% |
| Q3 2024 | 2024-09-30 | $12.2M | $7.7M | +172.89% |
| Q2 2024 | 2024-06-30 | $12.2M | $7.5M | +160.53% |
| Q1 2024 | 2024-03-31 | $34.9M | $31.1M | +826.35% |
| Q4 2023 | 2023-12-31 | $15.9M | −$99.8M | −86.27% |
| Q3 2023 | 2023-09-30 | $4.5M | −$12.5M | −73.78% |
| Q2 2023 | 2023-06-30 | $4.7M | −$16.1M | −77.44% |
| Q1 2023 | 2023-03-31 | $3.8M | −$36.4M | −90.62% |
| Q4 2022 | 2022-12-31 | $115.6M | — | — |
| Q3 2022 | 2022-09-30 | $17.0M | $1.6M | +10.42% |
| Q2 2022 | 2022-06-30 | $20.8M | — | — |
| Q1 2022 | 2022-03-31 | $40.1M | — | — |
| Q3 2021 | 2021-09-30 | $15.4M | — | — |
Biohaven stock-based compensation trends
Over the last five fiscal years, Biohaven's stock-based compensation increased from $29.5M to $112.4M, a change of $82.9M. The latest reported quarter, Q2 2026, shows $19.2M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biohaven source filings ↗